The logic behind Pfizer's purchase remains illusive. As to the revenue King was producing, you are correct. But that is not why companies acquire others. Any acquisition is done, not to acquire more revenues (analysts and shareholders would have a field day with management being unable to organically grow revenues), but to gain market entry, extend a line of products, gain a line of products, or gain synergies (and reduce overall costs). That is it...
News 
Market Data 
Discover 
